07:13 AM EST, 01/24/2023 — Johnson & Johnson (JNJ) reported Q4 adjusted earnings Tuesday of $2.35 per diluted share, up from adjusted earnings of $2.13 per share a year earlier.
Analysts polled by Capital IQ expected adjusted earnings of $2.24 per share.
Sales for the quarter ended Dec. 31 totaled $23.71 billion, down from $24.80 billion a year earlier.
Analysts surveyed by Capital IQ forecast sales of $23.90 billion.
For the full-year 2023, Johnson & Johnson (JNJ) said it expects adjusted EPS of $10.45 to $10.65 on sales of $96.90 billion to $97.90 billion. Analysts polled by Capital IQ are looking for adjusted earnings of $10.33 per share and sales of $97.73 billion, respectively.
Price: 169, Change: +0.69, Percent Change: +0.41
Leave a Reply